A Single-Center Pilot Study to Assess Macular Function

Completed

Conditions studied: Macular Degeneration

In brief

This study seeks to evaluate a novel endpoint for future dry AMD clinical trials.

Key facts

Study ID

NCT01204541

Run by

ORA, Inc.

People needed

24

Starts

2010-09-01

Expected to finish

2010-10-01

Last updated by the study team

2012-02-14

Who can join

Age: 20 and older, up to 90. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Subjects in good health aged 20-29 or 60-90 years (normal cohorts)
• Subjects with early non-exudative age-related macular degeneration (AMD cohort)

You may not qualify if…

• Enrollment in a investigational drug or device study and have used an investigational drug or device within 7 days of enrollment into this study

Where it is running

• Study site — Andover, Massachusetts, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.